Showing results (821-830 of 3,350) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|November 25, 2010
A systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and CanadaMark Oremus, S Carolina AguilarPharmacoeconomics|July 14, 2010
Economic burden of epilepsy among the privately insured in the USJasmina I Ivanova, Howard G Birnbaum, Yohanne Kidolezi, et al.Pharmacoeconomics|July 14, 2010
Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorderTatia Chay Woodward, Eskinder Tafesse, Peter Quon, et al.Pharmacoeconomics|December 16, 2010
Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisalMatt Stevenson, Abdullah PandorPharmacoeconomics|December 21, 2010
Consistently estimating absolute risk difference when translating evidence to jurisdictions of interestSimon Eckermann, Michael Coory, Andrew R WillanPharmacoeconomics|December 25, 2010
A review of economic evaluations of darunavir boosted by low-dose ritonavir in treatment-experienced persons living with HIV infectionJosephine Mauskopf, Lieven Annemans, Andrew M Hill, et al.Pharmacoeconomics|December 25, 2010
Costs to achieve undetectable HIV RNA with darunavir-containing highly active antiretroviral therapy in highly pretreated patients: the POWER experienceAndrew M Hill, Bonaventura Clotet, Margaret Johnson, et al.Pharmacoeconomics|December 25, 2010
Predicting direct costs of HIV care during the first year of darunavir-based highly active antiretroviral therapy using CD4 cell counts: evidence from POWERAndrew M Hill, Kelly Gebo, Lindsay Hemmett, et al.Pharmacoeconomics|May 15, 2010
Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisalAdrian Bagust, Janette Greenhalgh, Angela Boland, et al.Pharmacoeconomics|October 13, 2010
Economic implications of sleep disordersTracy L Skaer, David A SclarPageof 335